Artivion | CRY - Net Income

Stock Price
22.77
Daily Change
-0.16 -0.70%
Monthly
-38.02%
Yearly
-22.84%
Q2 Forecast
24.88

Artivion reported $2.42M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 108K 1.65M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 1.34B 669M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Inogen USD -5.96M 373K Sep/2024
Integra LifeSciences USD -4.62M 2.91M Mar/2026
J&J USD 5.24B 119M Mar/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -2.22M 20.57M Dec/2025
Pfizer USD 2.69B 4.34B Mar/2026
ResMed USD 398.73M 6.14M Mar/2026
Stryker USD 745M 104M Mar/2026
Surmodics USD -5.32M 6.22M Jun/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Terumo JPY 32.65B 2.4B Dec/2025
Trinity Biotech USD -5.14M 11.82M Sep/2025